Biognosys
Biotechnology Research • 
Schlieren, Zurich, Switzerland • 51-100 Employees
Company overview
| Headquarters | Wagistrasse 21, Schlieren, Zurich 8952, CH |
| Phone number | +41447382040 |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Data Analytics, Neuroscience, Drug Discovery, Artificial Intelligence, Oncology, Mass Spectrometry, Machine Learning, Rare Diseases, Immunology, Chronic Diseases, Biomarker Discovery And Validation, Discovery Proteomics, Hyper Reaction Monitoring (Hrm), Proteome Profiling, Targeted Proteomics, Clinical Studies, Proteomics Services, Contract Research Services, Proteomics Software, Pre-Clinical Research, Limited Proteolysis, Proteomics Kits, Quantitative Protein Analysis |
| Founded | 2008 |
| Employees | 51-100 |
| Socials |
Key Contacts at Biognosys
Biognosys Email Formats
Biognosys uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@biognosys.com), used 55.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@biognosys.com | 59.3% |
{first initial}.{last name} | j.doe@biognosys.com | 22.2% |
{last name} | doe@biognosys.ch | 14.8% |
{first name} | john@biognosys.com | 3.7% |
About Biognosys
The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making. Our Solutions We offer a versatile portfolio of proprietary proteomics services, software, and kits. We make these widely available for pharmaceutical and biotechnology researchers and proteomics experts. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all major sample types – cells, tissues, or body fluids – across human and non-human species. Our Technology Biognosys is the leading inventor and developer of mass spectrometry-based proteomics solutions. With market leading proteome coverage and sample throughput we enable simultaneous quantification of thousands of proteins across thousands of samples. Our Facility Biognosys’ high-end mass spectrometry facilities in Switzerland and the US provide world-leading capacity for proteomics contract research. From our two facilities, we make a broad spectrum of discovery, targeted, and structural proteomics solutions globally accessible. Our Data Competence Biognosys has analyzed a vast amount of proteomics data and developed an industry-leading understanding of the proteome. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research. Global Presence Founded in 2008 as a spin-off from the lab of proteomics pioneer Ruedi Aebersold at ETH Zurich, Biognosys today is an established leader in next-generation proteomics. With employees based across Switzerland, Europe, and US, and an extensive network of collaborators and distributors, Biognosys supports a global customer base of life science researchers across industry and academia.
Biognosys revenue & valuation
| Annual revenue | $6,800,000 |
| Revenue per employee | $76,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $21,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Biognosys has 64 employees across 13 departments.
Departments
Number of employees
Biognosys Tech Stack
Discover the technologies and tools that power Biognosys's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
JavaScript libraries
JavaScript libraries
Analytics
JavaScript libraries
CDN
Web servers
Advertising
SEO
Marketing automation
JavaScript libraries
Germany
Italy
Frequently asked questions
4.8
40,000 users
